[1] |
ROTH G A, MENSAH G A, JOHNSON C O,et al. Global burden of cardio-vascular diseases and risk factors,1990-2019:update from the GBD 2019 Study [J]. J Am Coll Cardiol, 2020, 76(25):2982- 3021. DOI: 10.1016/j.jacc.2020.11.010.
|
[2] |
GBD 2013 Mortality and Causes of Death Collaborators. Global,regional,and national age-sex specific all-cause and cause-specific mortality for 240 causes of death,1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2015, 385(9963):117-171. DOI: 10.1016/s0140-6736(14)61682-2.
|
[3] |
SHI S, TANG Y, ZHAO Q,et al. Prevalence and risk of atrial fibrillation in China:a national cross-sectional epidemiological study[J]. Lancet Reg Health West Pac, 2022, 23:100439. DOI: 10.1016/j.lanwpc.2022.100439.
|
[4] |
PSATY B M, MANOLIO T A, KULLER L H,et al. Incidence of and risk factors for atrial fibrillation in older adults[J]. Circulation, 1997, 96(7):2455-2461. DOI: 10.1161/01.cir.96.7.2455.
|
[5] |
GO A S, HYLEK E M, PHILLIPS K A,et al. Prevalence of diagnosed atrial fibrillation in adults:national implications for rhythm management and stroke prevention:the AnTicoagulation and Risk Factors in Atrial Fibrillation(ATRIA)Study[J]. JAMA, 2001, 285(18):2370-2375. DOI: 10.1001/jama.285.18.2370.
|
[6] |
STAERK L, SHERER J A, KO D,et al. Atrial fibrillation:epidemiology,pathophysiology,and clinical outcomes[J]. Circ Res, 2017, 120(9):1501-1517. DOI: 10.1161/CIRCRESAHA.117.309732.
|
[7] |
LIPPI G, SANCHIS-GOMAR F, CERVELLIN G. Global epidemiology of atrial fibrillation:an increasing epidemic and public health challenge[J]. Int J Stroke, 2021, 16(2):217-221. DOI: 10.1177/1747493019897870.
|
[8] |
THIHALOLIPAVAN S, MORIN D P. Atrial fibrillation and congestive heart failure[J]. Heart Fail Clin, 2014, 10(2):305-318. DOI: 10.1016/j.hfc.2013.12.005.
|
[9] |
WU J M, HOU Q Q, HAN Q L,et al. Atrial fibrillation is an independent risk factor for new-onset myocardial infarction:a prospective study[J]. Acta Cardiol, 2022:1-8. DOI: 10.1080/00015385.2022.2129184.
|
[10] |
BUNCH T J, WEISS J P, CRANDALL B G,et al. Atrial fibrillation is independently associated with senile,vascular,and Alzheimer's dementia[J]. Heart Rhythm, 2010, 7(4):433-437. DOI: 10.1016/j.hrthm.2009.12.004.
|
[11] |
RANGASWAMI J, BHALLA V, BLAIR J E A,et al. Cardiorenal syndrome:classification,pathophysiology,diagnosis,and treatment strategies:a scientific statement from the American heart association[J]. Circulation, 2019, 139(16):e840-878. DOI: 10.1161/cir.0000000000000664.
|
[12] |
|
[13] |
FAUCHIER L, BISSON A, CLEMENTY N,et al. Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation[J]. Am Heart J, 2018, 198:39-45. DOI: 10.1016/j.ahj.2017.12.017.
|
[14] |
BANERJEE A, HALIMI J, VOURC'H P,et al. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation:the Loire Valley Atrial Fibrillation Project[J]. Eur Heart J, 2013, 34(suppl_1):P5614. DOI: 10.1093/eurheartj/eht310.P5614.
|
[15] |
MURPHY A, BANERJEE A, BREITHARDT G,et al. The world heart federation roadmap for nonvalvular atrial fibrillation[J]. Glob Heart, 2017, 12(4):273-284. DOI: 10.1016/j.gheart.2017.01.015.
|
[16] |
CHUGH S S, ROTH G A, GILLUM R F,et al. Global burden of atrial fibrillation in developed and developing nations[J]. Glob Heart, 2014, 9(1):113-119. DOI: 10.1016/j.gheart.2014.01.004.
|
[17] |
中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会,中国房颤中心联盟心房颤动防治专家工作委员会,等. 心房颤动:目前的认识和治疗建议(2021)[J]. 中华心律失常学杂志,2022,26(1):15-88.
|
[18] |
|
[19] |
ZHANG C, GAO J, GUO Y,et al. Association of atrial fibrillation and clinical outcomes in adults with chronic kidney disease:a propensity score-matched analysis[J]. PloS One, 2020, 15(3):e0230189. DOI: 10.1371/journal.pone.0230189.
|
[20] |
韩全乐,毛瑞英,曹丽红,等. 射频消融对非瓣膜病心房颤动患者肾小球滤过率的影响[J]. 中国动脉硬化杂志,2017,25(12):1242-1246.
|
[21] |
POTPARA T S, FERRO C J, LIP G Y H. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction[J]. Nat Rev Nephrol, 2018, 14(5):337-351. DOI: 10.1038/nrneph.2018.19.
|
[22] |
FAUCHIER L, BISSON A, CLEMENTY N,et al. Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation[J]. Am Heart J, 2018, 198:39-45. DOI: 10.1016/j.ahj.2017.12.017.
|
[23] |
BÖHM M, EZEKOWITZ M D, CONNOLLY S J,et al. Changes in renal function in patients with atrial fibrillation:an analysis from the RE-LY trial[J]. J Am Coll Cardiol, 2015, 65(23):2481-2493. DOI: 10.1016/j.jacc.2015.03.577.
|
[24] |
HAN Q, ZHANG D, MAO R,et al. Research on the prevalence of chronic kidney disease and risk factors in northern populations of China[J]. Int J Clin Exp Med,2018,11(8):8585-8592.
|
[25] |
ZHANG L, WANG F, WANG L,et al. Prevalence of chronic kidney disease in China:a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. DOI: 10.1016/s0140-6736(12)60033-6.
|
[26] |
KHATIB R, JOSEPH P, BRIEL M,et al. Blockade of the renin-angiotensin-aldosterone system(RAAS)for primary prevention of non-valvular atrial fibrillation:a systematic review and meta analysis of randomized controlled trials[J]. Int J Cardiol, 2013, 165(1):17-24. DOI: 10.1016/j.ijcard.2012.02.009.
|
[27] |
HOLLANDER W. Role of hypertension in atherosclerosis and cardiovascular disease[J]. Am J Cardiol, 1976, 38(6):786-800. DOI: 10.1016/0002-9149(76)90357-x.
|
[28] |
BURSTEIN B, QI X Y, YEH Y H,et al. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function:a novel consideration in atrial remodeling[J]. Cardiovasc Res, 2007, 76(3):442-452. DOI: 10.1016/j.cardiores.2007.07.013.
|
[29] |
COHEN E, NARDI Y, KRAUSE I,et al. A longitudinal assessment of the natural rate of decline in renal function with age[J]. J Nephrol, 2014, 27(6):635-641. DOI: 10.1007/s40620-014-0077-9.
|
[30] |
FOX C S, LARSON M G, LEIP E P,et al. Predictors of new-onset kidney disease in a community-based population[J]. JAMA, 2004, 291(7):844-850. DOI: 10.1001/jama.291.7.844.
|
[31] |
|